Biotechnology/Chemical/Pharmaceutical Customer Partnership- September 14, 2015

 

The United States Patent and Trademark Office
Biotechnology, Chemical and Pharmaceutical (BCP) Partnership Meeting 

Monday, September 14, 2015

9:00am to 5:00pm (EDT)

 

We are pleased to announce the USPTO’s next Biotechnology, Chemical and Pharmaceutical Customer Partnership (BCP) Meeting. This upcoming BCP meeting will be jointly hosted by Technology Centers 1600 (Biotechnology and Organic Chemistry) and 1700 (Chemical and Materials Engineering). This BCP meeting expands our long-standing partnership in these industry sectors to customers across the country. The BCP Meeting will be held on September 14th and will be simultaneously available at locations in the USPTO Headquarters (Alexandria, VA) and the Midwest Regional Office (Detroit, MI). During this BCP, participants will be able to interact with Office personnel in person at both locations, or alternatively, via webcast. Please see below for Registration information on how you can participate.
Date and Location:  The Partnership Meeting will be held on September 14th (Monday) from 9:00am – 5:00pm at Alexandria, VA and, at the same time, at Detroit, MI

Headquarters Location:                            
USPTO Headquarters
Remsen Conference Center
400 Dulany Street
Alexandria, VA 22314

Midwest Regional Office  Location:
Elijah J. McCoy United States Patent and Trademark Office
300 River Place South,
Suite 2900
Detroit, MI 48207

The Biotechnology, Chemical and Pharmaceutical Customer Partnership was developed to create a collaborative forum for USPTO customers in this industry sector to share ideas, experiences, and insights with USPTO staff.  The BCP is intended to be informal in nature and will include participants from across the industry. 


         Some of the topics to be discussed by USPTO staff and stakeholders will include:
 

  •             Cooperative Patent Classification (CPC) Overview 
  •             Trends in Subject Matter Eligibility for Biotechnology Inventions (A Customer Perspective)
  •             Practitioner's Perspective on 101 as Applied to Biotech Applications
  •             Third Party Submission
  •             AIA 130 Declaration
  •             PCT National Stage Filing Tips
  •             Double Patenting

 

Please check back and click here to view the final BCP Agenda once posted. The USPTO looks forward to hearing the individual views from its customers and does not intend to use this forum to seek or arrive at any consensus.  This customer partnership is formed with full recognition of the USPTO's responsibility under the Federal Advisory Committee Act (FACA), and accordingly, is not established as FACA compliant committee. 

Registration Information

 

Please email USPTOBCP1600@USPTO.GOV to RSVP by September, 9th. Please include “BCP RSVP” in the email subject line.  In the email body, please include the following information:

  •                 Your name, title and organization
  •                 Contact information (e-mail, phone, etc.)
  •                 Your attending location (Alexandria, Detroit, or online).

 

                                       Agenda & Schedule

9:00 - 9:20AM (EDT) Welcoming and Opening Remarks  

Christal Sheppard, Director, Elijah J. McCoy USPTO (Detroit)

Jerry Lorengo, Director, TC1600, USPTO (Detroit)

Daniel Sullivan, Director, TC1600, USPTO (Alexandria)

Wanda Walker, Director, TC1600, USPTO (Alexandria)

Gladys Corcoran, Director, TC1700, USPTO (Alexandria)

Yvonne (Bonnie) Eyler, Director, TC1700, USPTO (Alexandria)

Karen Young, Director, TC1700, USPTO (Alexandria)

9:20 - 10:00 AM (EDT)

 Cooperative Patent Classification (CPC) Overview

 

 

Jerry Lorengo, Director, TC1600, USPTO (Detroit)

10:00 - 11:00 AM (EDT)

Practitioner's Perspective on 101 as Applied to Biotech Applications

Noel E. Day Ph.D. Partner, Honigman Miller Schwartz and Cohn LLP (Detroit)

11:00 - 11:10 AM (EDT) BREAK  
11:10 AM – 12:00 PM (EDT)

Trends in Subject Matter Eligibility for Biotechnology Inventions

  

Leslie T. Grab Ph.D., Associate Tina W. McKeon, Partner Kilpatrick Townsend & Stockton LLP (Alexandria)

12:50 - 1:00 PM (EST) LUNCH  
1:00 – 2:00 PM (EDT) Third Party Submission

Bennett Celsa, Quality Assurance Specialist, TC1600, USPTO (Alexandria)

2:00 – 3:00 PM (EDT) AIA 130 Declaration Kathleen Fonda, Senior Legal Advisor, Office of Patent Legal Administration (OPLA), USPTO (Alexandria)

3:10 – 3:50 PM (EDT)

Corrections/Amendments and Priority/Benefits Claims in International and National Stage

Susan Wolski, PCT Special Programs Examiner, International Patent Legal Administration, USPTO (Alexandria)

3:50 – 4:40 PM (EDT)

Double Patenting

James Wilson, Supervisory Patent Examiner (SPE), TC1600, USPTO (Alexandria)

4:40 – 5:00 PM (EDT)

 Closing Remarks

Directors

 

Directions and Parking information

Headquarters Location: USPTO Headquarters, Alexandria, Virginia       

      

WebEx info:

Please use the information below to join the meeting.  Send this information to your participants.

Date:  9/14/2015  9am-5pm

Topic: Biotech/Chemical/Pharmaceutical Customer Partnership Meeting
Host: Digital Multimedia1
Event number: 642 512 258
Event password: 12345
Registration password: This event does not require a password for registration

-------------------------------------------------------
To join the online event
-------------------------------------------------------
Click here to join the online event.
Or copy and paste the following link to a browser:
https://uspto-events2.webex.com/uspto-events2/onstage/g.php?MTID=ef04f1a7bc921509f7caab21adeb3a8a7

-------------------------------------------------------
To join the audio conference only
-------------------------------------------------------
To receive a call back, provide your phone number when you join the event, or call the number below and enter the access code.
US TOLL FREE: +1-855-282-6330
US TOLL: +1-415-655-0003
Toll-free dialing restrictions: http://www.webex.com/pdf/tollfree_restrictions.pdf
Access code: 642 512 258